Sage Journals: Discover world-class research

Open access

Research article

First published 2022

Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD

Yiwen Gong, Yinghua Lv, Hongxia Liu [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2020

LABA/LAMA fixed-dose combinations versus LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis

Ching-Yi Chen, Wang-Chun Chen, Chi-Hsien Huang [...]

Therapeutic Advances in Respiratory Disease

Free access

Research article

First published 2013-12

The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects

Gregory J. Feldman, Anton Edin

Therapeutic Advances in Respiratory Disease

Retricted access

Review article

First published 2017-8

Role of Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist Therapy in Chronic Obstructive Pulmonary Disease

Sarah E. Petite

Annals of Pharmacotherapy

Retricted access

Research article

First published 2017-11

Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β 2 -Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid

Jennifer C. Samp, Min J. Joo, Glen T. Schumock [...]

Annals of Pharmacotherapy

Open access

Review article

First published 2023

Stepwise management of COPD: What is next after bronchodilation?

Marc Miravitlles, Kazuto Matsunaga, Michael Dreher

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2023

The future exacerbation and mortality of different inhalation therapies among patients with chronic obstructive pulmonary disease in various GOLD groups: a focus on the GOLD 2017 and GOLD 2023 reports

Qing Song, Wei Cheng, Cong Liu [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2024

Long-acting muscarinic antagonist and long-acting β 2 -agonist combination for the treatment of maintenance therapy–naïve patients with chronic obstructive pulmonary disease: a narrative review

Roland Buhl, Marc Miravitlles, Antonio Anzueto [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2019

Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β 2 -agonist fixed-dose combinations in COPD

Mohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2021

Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction

Alessandro Celi, Manuela Latorre, Pierluigi Paggiaro [...]

Sage Open Chronic Disease

Search results